Roche, Regeneron join forces on COVID-19 antibody
Despite hundreds of potential therapies for COVID-19 looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody cocktail, has earned early plaudits—and now a pharma giant is jumping aboard to boost manufacturing in a big way.
Regeneron will team up with Swiss drugmaker Roche to more than triple production of the New York biotech's COVID-19 antibody therapy, REGN-COV2, for a planned global rollout, the partners said Wednesday.
Under a seven-year licensing deal, Regeneron and Roche will each reserve manufacturing capacity for the therapy in preparation for future regulatory approvals, with Regeneron handling the U.S. rollout and Roche taking on distribution elsewhere.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dawn Seizes Strategic Control of EPDM Supply Chain with Acquisition of Ningbo SK—A Bold Leap Toward Global Elasticity
-
Dow Sounds the Alarm in Southeast Asia: Polymer MDI Prices Jump by $200/ton Amid Market Turbulence
-
Mitsubishi Chemical Announces Expansion of Advanced Carbon Fiber Production Capacity in Japan and the United States
-
BASF to Sell Optical Brighteners Business to Catexel
-
BASF Evaluates New MDI Production Complex in India, Secures Dahej Site
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Fracturing the Crown: BASF Antwerp’s 600-Job Cut and the Global Alarm
-
Lotte Chemical Plans Sale of Selected Operations in Malaysia, Indonesia, and the United States
-
Wanhua’s Counter-Cyclical Expansion: A Gamble or a Strategic Move for the Next Cycle?
-
Dafeng Haijianuo’s RMB 246 Million Technical Revamp Project Takes Shape, with Multiple Production Lines for Vitamin K1, Folic Acid, and Others Under Construction
Recommend Reading
-
![BASF Battles Market Turmoil as Profits Slide]()
BASF Battles Market Turmoil as Profits Slide
-
![Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China]()
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
![BASF Approves €1 Billion Share Buyback Program as Chemical Giant Prioritizes Capital Discipline]()
BASF Approves €1 Billion Share Buyback Program as Chemical Giant Prioritizes Capital Discipline
-
![Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes]()
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
![Wanhua Chemical Is Fighting Counterfeits While Raising Prices]()
Wanhua Chemical Is Fighting Counterfeits While Raising Prices
-
![Recent Weak Performance of Polyethylene in China]()
Recent Weak Performance of Polyethylene in China
-
![Today, PET polyester bottle flakes rebound strongly (12.19)]()
Today, PET polyester bottle flakes rebound strongly (12.19)
-
![In November, PVC Continues to Decline, Market Shows Signs of Stabilization]()
In November, PVC Continues to Decline, Market Shows Signs of Stabilization
-
![This Week's Styrene Market Weakens and Falls (12.15-12.19)]()
This Week's Styrene Market Weakens and Falls (12.15-12.19)
-
![November Natural Rubber Market Prices Fluctuate and Rise Slightly in China]()
November Natural Rubber Market Prices Fluctuate and Rise Slightly in China
